Özet:

Purpose: The purpose of this study is to document and analyze the data of clinical, imaging, pathological and postoperative monitoring findings of patients with thyroid carcinoma (MTK). Method: 11 patients were included. All patients were operated and the type of surgery was certified. The clinical characteristics and imaging characteristics of these patients, pre- and post-operative calcitonin and carcinomembriogenic antigen (CEA) levels and pre-operative thyroid stimulating hormone (TSH) levels were reverse reviewed. The demographic characteristics of the patients are listed. Results: The average age is 53.7 ± 12.8, the average nodule size is 27 ± 18 mm. The average preoperative TSH value was 1.1 ± 1.0 mIU / L, the average calcitonin and CEA values were 898 (10,9-1747) pq/mL and 98,1 (44-196) ng/mL respectively. All patients received total thyroidectomy + central/lateral lymph nod disection. According to the results of preoperative thin injection aspiration biopsy (IAB), two (18.2%) patients were to be in Bethesda 2, one (9.1%) in Bethesda 4 and 8 (72.7%) patients were to be in MTK. 7 of the patients (63.6%) were in the early stages, and 4 (36.4%) were in the localization advanced stages. One patient was rated RET oncogenic positive hereditary MTC and 10 patients were rated as sporty MTK. During the follow-up, 1 (9.1%) of the patient was lost due to lung metastasis. Result: Clinical and imaging findings for preoperative diagnosis of MTK, cytology and serum calcitonin and CEA levels, genetic tests should be thoroughly evaluated. As a clinical approach, pre-operative calcitonin and CEA measurements should be taken in patients with thyroid nodules planned for thyroidectomy.